New York State Teachers Retirement System trimmed its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 675,844 shares of the medical research company’s stock after selling 5,543 shares during the quarter. New York State Teachers Retirement System owned 0.17% of Thermo Fisher Scientific worth $127,870,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in TMO. Amalgamated Bank increased its position in Thermo Fisher Scientific by 57.0% during the second quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock valued at $7,837,000 after acquiring an additional 16,308 shares during the last quarter. Mutual of America Capital Management LLC increased its position in Thermo Fisher Scientific by 2.1% during the second quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock valued at $8,327,000 after acquiring an additional 977 shares during the last quarter. Mitchell Capital Management Co. increased its position in Thermo Fisher Scientific by 40.3% during the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after acquiring an additional 12,910 shares during the last quarter. State Board of Administration of Florida Retirement System grew its holdings in Thermo Fisher Scientific by 0.9% during the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock valued at $101,317,000 after purchasing an additional 5,213 shares during the period. Finally, San Francisco Sentry Investment Group CA bought a new stake in Thermo Fisher Scientific during the second quarter valued at about $1,451,000. 86.16% of the stock is currently owned by institutional investors and hedge funds.
Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded up $1.76 during midday trading on Thursday, hitting $185.63. The stock had a trading volume of 1,550,058 shares, compared to its average volume of 1,561,300. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. Thermo Fisher Scientific Inc has a 12-month low of $139.88 and a 12-month high of $201.20. The stock has a market capitalization of $73,161.61, a P/E ratio of 20.05, a price-to-earnings-growth ratio of 1.67 and a beta of 1.06.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. Thermo Fisher Scientific’s quarterly revenue was up 13.9% on a year-over-year basis. During the same period last year, the business posted $2.03 EPS. research analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.60 annualized dividend and a yield of 0.32%. Thermo Fisher Scientific’s payout ratio is currently 10.19%.
Several research firms have issued reports on TMO. Leerink Swann reissued an “outperform” rating and set a $200.00 price target (down previously from $216.00) on shares of Thermo Fisher Scientific in a report on Monday. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a research note on Tuesday, October 31st. Deutsche Bank set a $226.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. Jefferies Group reaffirmed a “hold” rating and issued a $195.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Finally, Goldman Sachs Group started coverage on Thermo Fisher Scientific in a research note on Tuesday, September 26th. They set a “buy” rating and a $225.00 price target for the company. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $205.21.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the transaction, the chief executive officer now directly owns 252,577 shares in the company, valued at approximately $47,582,981.03. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.49% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc (TMO) Shares Sold by New York State Teachers Retirement System” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/07/thermo-fisher-scientific-inc-tmo-shares-sold-by-new-york-state-teachers-retirement-system.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.